Gynecologic Oncology

Surgical Staging of Endometrial Cancer: Does the Patient Benefit?
pp. 335-339(5)
Author: Orr J.W.

Lymph Node Sampling and Survival in Endometrial Cancer
pp. 340-343(4)
Authors: Trimble E.L.; Kosary C.; Park R.C.

Influence of Postoperative Treatment on Survival in Patients with Uterine Papillary Serous Carcinoma
pp. 344-347(4)
Authors: Bancher-Todesca D.; Neunteufel W.; Williams K.E.; Prainsack D.; Breitenecker G.; Friedlander M.L.; Hacker N.F.

Gastrostomy Using a ''Gastrofix'' as an Alternative for Nasogastric Tubes in Ovarian Cancer Surgery
pp. 348-351(4)
Authors: Amant F.; Berteloot P.; Vergote I.

p53Mutations and Presence of HPV DNA Do Not Correlate with Radiosensitivity of Gynecological Cancer Cell Lines
pp. 352-358(7)
Authors: Rantanen V.; Grenman S.; Kurvinen K.; Hietanen S.; Raitanen M.; Syrjanen S.

Does Glutamine Supplementation Increase Radioresistance in Squamous Cell Carcinoma of the Cervix?
pp. 359-363(5)
Authors: Santoso J.T.; Lucci J.A.; Coleman R.L.; Hatch S.; Wong P.; Miller D.; Mathis J.M.

Phorbol 12-Myristate 13-Acetate Stimulates Lysophosphatidic Acid Secretion from Ovarian and Cervical Cancer Cells but Not from Breast or Leukemia Cells
pp. 364-368(5)
Authors: Shen Z.; Belinson J.; Morton R.E.; Xu Y.; Xu Y.

Perceptions of Cisplatin-Related Toxicity among Ovarian Cancer Patients and Gynecologic Oncologists
pp. 369-375(7)
Authors: Calhoun E.A.; Bennett C.L.; Peeples P.A.; Lurain J.R.; Roland P.Y.; Weinstein J.M.; Fishman D.A.

Identification of Persistent Trophoblastic Diseases Based on a Human Chorionic Gonadotropin Regression Curve by Means of a Stepwise Piecewise Linear Regression Analysis after the Evacuation of Uneventful Moles
pp. 376-380(5)
Authors: Shigematsu T.; Kamura T.; Saito T.; Kaku T.; Nakano H.; Kinugawa N.

Intraperitoneal Pressures and Clinical Parameters of Total Paracentesis for Palliation of Symptomatic Ascites in Ovarian Cancer
pp. 381-385(5)
Authors: Gotlieb W.H.; Feldman B.; Feldman-Moran O.; Zmira N.; Kreizer D.; Segal Y.; Elran E.; Ben-Baruch G.

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon- in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial
pp. 386-390(5)
Authors: Weiss G.R.; Liu P.Y.; Alberts D.S.; Peng Y.-M.; Fisher E.; Xu M.J.; Scudder S.A.; Baker L.H.; Moore D.F.; Lippman S.M.

PTENMutations in Endometrial Cancers with 10q LOH: Additional Evidence for the Involvement of Multiple Tumor Suppressors
pp. 391-395(5)
Authors: Simpkins S.B.; Peiffer-Schneider S.; Mutch D.G.; Gersell D.; Goodfellow P.J.

Differential Inhibitory Effects on Human Endometrial Carcinoma Cell Growth of Luteinizing Hormone-Releasing Hormone Analogues
pp. 396-403(8)
Authors: Borri P.; Coronnello M.; Noci I.; Pesciullesi A.; Peri A.; Caligiani R.; Maggi M.; Torricelli F.; Scarselli G.; Chieffi O.; Mazzei T.; Mini E.

Cervicography and HPV DNA Testing as Triage Criteria for Patients with Abnormal Pap Smear
pp. 404-409(6)
Authors: Costa S.; Sideri M.; Bucchi L.; Schettino F.; Maini I.; Spinaci L.; Bovicelli L.; Terzano P.

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study
pp. 410-415(6)
Authors: Feun L.G.; Blessing J.A.; Major F.J.; DiSaia P.J.; Alvarez R.D.; Berek J.S.

Chemotherapy Using 5-Fluorouracil and Nitrocaphanum in Malignant Trophoblastic Tumor
pp. 416-419(4)
Authors: Wang Y.; Jiu L.; Guan Y.; Qiu D.

The Chemotactic Cytokine Interleukin-8-A Cyst Fluid Marker for Malignant Epithelial Ovarian Cancer?
pp. 420-423(4)
Authors: Ivarsson K.; Runesson E.; Sundfeldt K.; Haeger M.; Hedin L.; Janson P.O.; Brannstrom M.

Preoperative Ultrasound Study in Predicting Lymph Node Metastasis for Endometrial Cancer Patients
pp. 424-427(4)
Authors: Cheng W.-F.; Chen C.-A.; Lee C.-N.; Chen T.-M.; Huang K.-T.; Hsieh C.-Y.; Hsieh F.-J.

Missed Opportunities for Cervical Cancer Screening of HMO Members Developing Invasive Cervical Cancer (ICC)
pp. 428-430(3)
Authors: Kinney W.; Sung H.-Y.; Kearney K.A.; Miller M.; Sawaya G.; Hiatt R.A.

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
pp. 431-436(6)
Authors: Vergote I.; De Wever I.; Tjalma W.; Van Gramberen M.; Decloedt J.; van Dam P.

Histological Features of the Contralateral Ovary in Patients with Unilateral Ovarian Cancer: A Case Control Study
pp. 437-441(5)
Authors: Tresserra F.; Grases P.J.; Labastida R.; Ubeda A.

CA 125 Is Dominantly Expressed by Arrest of G0/G1 Phase in Uterine Cervical Adenocarcinoma Cell Line
pp. 442-449(8)
Authors: Hayashi T.; Hayakawa O.; Kudo R.

A Phase I Study of Paclitaxel, Doxorubicin, and Cisplatin in Patients with Previously Untreated Epithelial Ovarian Cancer
pp. 450-453(4)
Authors: Naumann R.W.; Alvarez R.D.; Omura G.A.; Segars E.; Kilgore L.C.; Partridge E.E.

Rare Case of Small-Cell Carcinoma Arising from the Endometrium with Paraneoplastic Retinopathy
pp. 454-457(4)
Authors: Sekiguchi I.; Suzuki M.; Sato I.; Ohkawa T.; Kawashima H.; Tsuchida S.

Low-Grade Endometrial Stromal Sarcoma Preoperative Treatment with Depo-Lupron and Megace
pp. 458-460(3)
Authors: Scribner D.R.; Walker J.L.

Signet Ring Breast Carcinoma Metastases Limited to the Endometrium and Cervix
pp. 461-464(4)
Authors: Kennebeck C.H.; Alagoz T.

Elevated Serum Inhibin and Tumor-Associated Trypsin Inhibitor Concentrations in a Young Woman with Dysgerminoma of the Ovary
pp. 465-468(4)
Authors: Santala M.; Burger H.; Ruokonen A.; Stenback F.; Kauppila A.

Primary Transitional Cell Carcinoma of the Fallopian Tube: A Case Report and Review of the Literature
pp. 469-475(7)
Authors: Chin H.; Matsui H.; Mitsuhashi A.; Nagao K.; Sekiya S.

Malignant Melanoma of the Vagina and Locoregional Control: Radical Surgery Revisited
pp. 476-480(5)
Authors: Irvin W.P.; Bliss S.A.; Rice L.W.; Taylor P.T.; Andersen W.A.

Papers to Appear in Forthcoming Issues
pp. 481-481(1)

Author Index for Volume 71
pp. 482-484(3)

Cumulative Subject Index for Volumes 68-71
pp. 485-500(16)